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Abstract
Background: The prevalence of childhood obesity has increased worldwide, which is a serious concern as obesity
is associated with many negative immediate and long-term health consequences. Therefore, the treatment of
overweight and obesity in children and adolescents is strongly recommended. Inpatient weight-loss programs
have shown to be effective particularly regarding short-term weight-loss, whilst little is known both on the long-
term effects of this treatment and the determinants of successful weight-loss and subsequent weight maintenance.
The purpose of this study is to evaluate the short, middle and long-term effects of an inpatient weight-loss
program for children and adolescents and to investigate the likely determinants of weight changes, whereby the
primary focus lies on the potential role of differences in polymorphisms of adiposity-relevant genes.
Methods/Design: The study involves overweight and obese children and adolescents aged 6 to 19 years, who
participate in an inpatient weight-loss program for 4 to 6 weeks. It started in 2006 and it is planned to include
1,500 participants by 2013. The intervention focuses on diet, physical activity and behavior therapy. Measurements
are taken at the start and the end of the intervention and comprise blood analyses (DNA, lipid and glucose
metabolism, adipokines and inflammatory markers), anthropometry (body weight, height and waist circumference),
blood pressure, pubertal stage, and exercise capacity. Physical activity, dietary habits, quality of life, and family
background are assessed by questionnaires. Follow-up assessments are performed 6 months, 1, 2, 5 and 10 years
after the intervention: Children will complete the same questionnaires at all time points and visit their general
practitioner for examination of anthropometric parameters, blood pressure and assessment of pubertal stage. At
the 5 and 10 year follow-ups, blood parameters and exercise capacity will be additionally measured.
Discussion: Apart from illustrating the short, middle and long-term effects of an inpatient weight-loss program,
this study will contribute to a better understanding of inter-individual differences in the regulation of body weight,
taking into account the role of genetic predisposition and lifestyle factors.
Trial Registration: NCT01067157.
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The global increase in childhood overweight and obesity
is a serious health concern [1], as it often tracks into
adulthood [2] where it is associated with numerous car-
diovascular and metabolic risk factors such as hyperten-
sion, type 2 diabetes or hyperlipidemia and even
cardiovascular disease [3,4]. In addition, even at young
age, overweight and obesity are related with various
physical and psychological comorbidities. For instance, it
has been found that overweight and obese children and
adolescents often suffer from elevated blood pressure,
dyslipidemia or disorders of glucose metabolism [5], and
have a lower quality of life compared to healthy normal
weight children [6].
Obesity and inflammation
The link between adiposity and the development of
metabolic and cardiovascular diseases may be seen in
obesity-related systemic inflammation [7,8]. Hypertrophy
and hyperplasia of the adipose tissue as seen in obesity
result in a dysfunction of the adipocytes [9], which
increases inflammation and impairs hemostasis, glucose
as well as lipid metabolism [7,8]. This is triggered by an
alteration of the secretion of the adipokines adiponectin,
leptin, retinol binding protein 4 (RBP4) and resistin as
well as inflammatory markers such as interleukin 6 (IL-
6), tumor necrosis factor-a (TNF-a) and C-reactive pro-
tein (CRP). For example, a decrease in adiponectin and
an increase of RBP4 as often found in obese individuals
may foster the development of insulin resistance.
Furthermore, elevated levels of RBP4, IL-6 and TNF-a
increase the inflammatory status by directly stimulating
CRP synthesis in the liver [9].
In contrast, physical activity and/or weight-loss seem
to have a positive impact on these mechanisms by
improving the inflammatory status and reducing insulin
resistance. However, data concerning these mechanisms
in children are scarce and results from the existing stu-
dies have been inconsistent [9,10]. In addition, simulta-
neous measurements of adipokines, inflammatory
markers, and cardiovascular risk factors of obese chil-
dren before and after a short-term lifestyle intervention
and at a long-term follow-up during late adolescence or
adulthood have not been performed before.
The role of genes
Weight gain due to an increase in adipose tissue is the
result of an imbalance between energy expenditure and
energy intake. This balance can be influenced by both
physical activity and caloric intake, which can be depen-
dent on social, psychological and other behavioral fac-
tors. In addition, genes have been shown to play a
fundamental role in the regulation of body weight
[1,11]. Apart from very rare monogenetic disorders [12],
a genetically determined higher risk for obesity can
often be attributed to a polygenetic pattern involving
different single nucleotide polymorphisms (SNP’s). For
instance, variations in the FTO-gene seem to have an
effect on the development of early onset obesity. Like-
wise, a study by Frayling et al. has shown that a single-
nucleotide polymorphism of the SNP rs9939609Aa l l e l e
is associated with an increased risk of overweight (odds
ratio 1.18; 95% CI = 1.13 to 1.24) and obesity (odds
ratio 1.31; 95% CI = 1.23 to 1.39), increasing the risk by
20-30%. Additionally, the A allele of the rs9939609 SNP
has been found to be associated with an increased body
mass index (BMI) in 7 year old children and to also
determine obesity during puberty and beyond [13].
Furthermore loci associated with neuronal pathways
(TMEM18, GNPDA2, SH2B1, NEGR1) have recently
been identified to be associated with childhood obesity
[14]. It has to be noted though that these genetic predis-
positions may only lead to an obesity phenotype in the
presence of an obesogenic environment, and therefore
this association may be modified by a lifestyle interven-
tion [15,16].
Lifestyle interventions to treat childhood obesity
Due to the tremendous short and long-term health con-
sequences, current recommendations strongly encourage
the treatment of childhood obesity, which may be per-
formed in an outpatient or an inpatient setting (e.g. resi-
dential or weight-loss camps), or by a combination of
both. However, the effectiveness of these types of pro-
grams remains uncertain [17]. In a recent review by
Kelly and Kirschenbaum the average decrease in percent
overweight within inpatient treatment across 11 studies
was reported 23.9% from pre to post-intervention and
20.6% from pre-intervention to follow-up, whereas the
effect on percent overweight was 8.5% and 8.9% for out-
patient programs, respectively [18]. Within the EvAKuJ-
study (Evaluation of obesity treatment in children and
adolescents study) the short and long-term effects of dif-
ferent German childhood-obesity programs were
assessed [19]. The authors reported that five out of 48
programs included took place in an inpatient setting
(875 patients), whereas all others were carried out in an
outpatient setting (1,041 patients). Children participating
in inpatient programs achieved a mean reduction in
BMI-SDS (BMI standard deviation score [20,21]) of
-0.36 during the treatment and of -0.17 during the
observational follow-up 1-2 years after termination of
the treatment, whereas this was -0.18 and -0.21 for out-
patient programs, respectively [19]. In summary, the
results of inpatient versus outpatient programs are equi-
vocal especially regarding long-term effectiveness.
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treatment programs have been evaluated, and these stu-
dies are heterogeneous regarding their study design and
overall quality. For instance, the treatment duration
ranges from 10 days to 10 months and only 29% of the
studies included a follow-up period. The range in fol-
low-up duration also varies dramatically (4 months to
4.6 years) and about half (46%) of the studies performed
a follow-up after less than 1 year [18,22,23]. A study by
Braet and van Winckel is the only one with a follow-up
period of more than 3 years from the start of the inter-
vention, however, they have not carried out blood ana-
lyses and the sample size of their inpatient treatment
group was rather low [24].
These results emphasize that inpatient treatment
might be the most effective strategy for children to
loose body weight in the short-term, but that there is a
substantial need for intervention studies with consider-
ably longer duration of follow-up and a standardized
protocol of the intervention and analyses. In addition,
only very few studies have reported on the influence of
lifestyle intervention in obese children whilst consider-
ing genetic predisposition [25-30].
Methods/Design
Objectives
To investigate the determinants for short, middle and
long-term weight-loss and weight maintenance, a pro-
spective cohort study involving overweight and obese
children and adolescents (hereafter referred to as ‘chil-
dren’) is being conducted, which includes a short-term
inpatient weight-loss program complemented by a long-
term observational follow-up over 10 years. Measure-
ments include anthropometric, cardiometabolic and
genetic parameters as well as assessment of physical
activity and fitness, dietary habits and quality of life.
Primary endpoint
The associations between polymorphisms in adiposity-
relevant genes (e.g. FTO, MC4R, TMEM-18)o nt h e
changes in BMI and BMI-SDS after a controlled lifestyle
intervention (4 to 6 weeks) in overweight and obese
children and adolescents.
Secondary endpoints
The short (4 to 6 weeks), middle (6 to 12 months) and
long-term (2, 5 and 10 years) effects of the intervention
on the below-listed parameters and their associations
with polymorphisms in adiposity-relevant genes (e.g.
FTO, MC4R, TMEM-18):
￿ anthropometric parameters
￿ parameters of lipid and glucose metabolism
￿ adipokines and inflammatory markers
￿ physical fitness
￿ physical activity
￿ dietary behavior and intake
￿ health-related quality of life
Participants
Participants of the LOGIC-trial (Long-term effects of
lifestyle intervention in Obesity and Genetic Influence
in Children) are 6 to 19 year old overweight and obese
children, who are referred to the rehabilitation center
Klinik Schönischt in Berchtesgaden, Germany by their
local pediatrician to have inpatient weight-loss treat-
ment. The clinic is specialized on childhood obesity and
about 200 children with the primary diagnosis over-
weight/obesity are being treated here annually.
Children are admitted to the clinic on a biweekly basis
and recruited consecutively by scientists from the
Department of Prevention, Rehabilitation and Sports
Medicine, Technical University of Munich. In case they
fulfill the inclusion criteria (see Table 1), assent and
informed consent for study participation are obtained
from the children and their accompanying legal
guardians.
The study is conducted according to the declaration of
Helsinki (Seoul, 2008) and approved by the ethics com-
mittee of the Faculty of Medicine of the Technische
Universität München, Germany (1354/05).
Recruitment process
Recruitment for this collaborative study began in Janu-
ary 2006 with the aim to include a total of 1,500 partici-
p a n t sb y2 0 1 3 .F i g u r e1s h o w st h ef l o wc h a r to ft h e
recruitment and the measurement process.
Table 1 Inclusion and exclusion criteria for participation in the LOGIC-trial
Inclusion criteria Exclusion criteria
Eligibility criteria for attending the
inpatient weight-loss program at the Klinik
Schönsicht
Overweight (BMI 90.-97
th percentile), obese (BMI 97.-
99.5
th percentile) or severely obese (BMI > 99.5
th
percentile)
Repeated failure to accomplish weight-loss in
outpatient therapies
Considerable mental or physical disability
Severe personality disorders
Suicidal behavior
Drug addiction
Eligibility criteria for LOGIC-trial
participation
Written informed consent by participant and a legal
guardian
Obesogenic diseases and disorders such as
the Prader-Willi Syndrome, Cushing
Syndrome
Early withdrawal from the inpatient
program (< 3 weeks)
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the end of the intervention (generally after 4 to 6 weeks;
Visit 2) at the clinic. Follow-up examinations are per-
formed at 6 months (Visit 3), 1 year (Visit 4), 2 years
(Visit 5), 5 years (Visit 6) and 10 years (Visit 7) after the
start of the intervention by either local pediatricians or
general practitioners (Figure 1).
Intervention
The rehabilitation clinic is primarily focused on inpati-
ent treatment for childhood overweight and obesity
which typically lasts for 4 to 6 weeks. The duration of
the stay depends on health insurance allowance and the
severity of obesity. Typically the children are referred to
the clinic for 4 weeks and in case of severe obesity or
comorbidities they have the opportunity to extend the
program. The standardized multimodal program focuses
on a calorie restricted balanced diet, an increase in phy-
sical activity and behavioral counseling. It is conducted
by an interdisciplinary team of pediatricians, exercise
physiologists, dieticians, psychologists and pedagogues
according to German guidelines for inpatient weight-
loss programs (AGA, Arbeitsgemeinschaft Adipositasim
Kindes- und Jugendalter) [31].
The children are offered an optimized balanced diet
prepared according to current guidelines (30%, 15% and
55% of the total energy content from fat, proteins and
carbohydrates, respectively), with an allowed energy
intake of 1,250-1,800 kcal
a per day, depending on height
and sex (Table 2) [32]. The components of the interven-
tion program are shown in Table 3. In brief, the chil-
dren are required to participate in theoretical and
practical lessons on healthy eating, physical activity and
behavior change skills based on the cognitive-behavioral
theory. The exercise therapy consists of approximately
10 h of organised physical activity per week,
b in addition
to 6 hours of recreational exercise.
Measurements
An overview of all measurements at the different time
points (Visits 1-7) is presented in Table 4. During the
inpatient treatment, the physical examination is performed
on the day of admission and on the day of discharge.
Blood samples are taken on the third day after admission
to the clinic and 3 days before discharge (except for DNA
samples, which are taken only at baseline). Physical fitness
testing is performed and questionnaires are filled in on the
first weekend after admission to the clinic and 1 to 2 days
before discharge. In case children extend the treatment, all
examinations are being conducted after 6 weeks. Ques-
tionnaires are filled in without supervision.
Physical examination
Body height is measured barefoot to the nearest 0.5 cm
by a rigid stadiometer. Body weight is measured with
Figure 1 Study flow chart of the LOGIC-trial.
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(Visit 1 and 2: Tanita BC-420 P MA Profi, Tanita Eur-
ope B.V., Hoofddorp, The Netherlands; Visits 3-7: cali-
brated scale). Waist circumference is measured on bare
skin by tape to the nearest 0.1 cm midway between the
lower rib margin and the iliac crest in standing position
after normal exhalation with a non-stretchable tape
measure. Blood pressure is measured at the right bra-
chial artery in the fossa cubitalis after the children have
been resting for 5 min in supine position by using a
validated protocol [33]. Pubertal development is deter-
mined according to Marshall and Tanner [34,35]. Data
on the medical history are documented including cur-
rent medication and comorbidities (orthopedic compli-
cations, attention deficit (hyperactivity) disorders,
thyroidal diseases, asthma, metabolic diseases, psycholo-
gical diseases, acute diseases). All inpatient examinations
and assessments are conducted by trained medical staff
according to standardized procedures.
Blood samples
Blood sampling is performed following a 10 hour over-
night fast. Samples are taken by venipuncture of an
antecubital vein in either a sitting or lying position
using vacuum tubes. Both plasma and serum samples
are stored at -80°C until analyzed. The following para-
meters will be analyzed from serum: high density lipo-
protein (HDL), low density lipoprotein (LDL), total
cholesterol, triglycerides, glucose, proinsulin, insulin,
uric acid, TSHbasal, adiponectin, leptin, RBP4, resistin,
high sensitive CRP, IL-6 and TNF-a.
Genetic analysis
Genomic DNA for all subjects is stored at -20°C after
isolation from EDTA blood following a standard proto-
col. In a first step several SNPs were selected from Hap-
Map CEU data (release 21 phase II, dbSNP 125)
including SNPs with minor allele frequencies > 5% in
genes of interest for the phenotypes available (e.g. body
weight, physical fitness, risk factor profile). In a first
step, genotyping was performed using the MassARRAY
system with iPLEX™ Gold chemistry (Sequenom,S a n
Diego, CA, USA). The samples were analyzed in a
matrix-assisted laser desorption ionisation time of flight
mass spectrometer (MALDI TOF MS, BrukerDaltonik,
Leipzig, Germany). Further analyses will be performed
using state of the art genotyping methods.
Physical activity and cardiovascular fitness
Physical activity is assessed by a questionnaire and by
pedometers. Cardiovascular fitness is assessed by both
cycle ergometry and a 6-Minutes running test.
The physical activity questionnaire has been adapted
to the MOMO questionnaire, which has been previously
validated [36,37]. Items of the questionnaire include
volume, frequency, duration and intensity of school,
sports clubs and/or leisure time activities, motivation to
be physically active [38] as well as questions on seden-
tary time (screen time and homework). Between 2008
and 2010 all study participants were asked to wear a
pedometer (OMRON Walking Style Pro) all day for 2 to
4 weeks during their inpatient stay at the clinic. They
also completed a physical activity diary for these days.
Exercise testing is performed stepwise on a cycle erg-
ometer (Jaeger ERGOSTESTER 900) to the participants’
volitional exhaustion. Absolute or relative exercise capa-
city (Watt, Watt/kg) is used as a measure of cardiovascu-
lar fitness. Since 2008 the study participants have been
taking part in a 6 min running test. For this test, which
takes place on a straight outdoor sports ground, the chil-
dren are asked to walk or run as far as possible within 6
min. The covered distance is documented in metres.
Diet
For the assessment of dietary intake, a food frequency
recall is used, which has been validated previously in a
survey [39].
Quality of life
To assess quality of life, the validated German KINDL
R-
questionnaire [40,41] with six dimensions ("physical
well-being”, “emotional well-being”, “self-esteem”,
“friends”, “family” and “everyday functioning (school)”)
is being used. The subscales of these six dimensions are
combined to a total score. Furthermore, an additional
sub-scale, developed specifically to assess the quality of
life of overweight children, is being used, which consists
of a filter question and six items. The reliability and
validity of this questionnaire have been described else-
where [41].
In addition, a standardized questionnaire that is sup-
posed to be completed by the parents on the day of
admission is being used to obtain demographic informa-
tion as well as obesity-related health history of first
degree family members.
Table 2 Calculation of the allowed energy intake based on body height and sex
Boys Girls
Height [cm] Energy intake per day [kcal] Height [cm] Energy intake per day [kcal]
≤ 145 1250 ≤ 155 1250
146-170 1500 156-180 1500
≥ 171 1800 ≥ 181 1800
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Intervention
component
Items Description Aims Frequency/Dose
Structured
physical activity
(10 h/week)
Therapeutic
sports
Different types of outdoor activities
such as ascending stairs, road running
and cross country runs etc.
Endurance training according to
individual abilities
2x/week à 60 min
Swimming Lane swimming ~1.000 m Endurance training;
Learning/improving swimming
technique
1x/week à 50 min
plus the 6 km walk to the pool (~3
km downhill, 3 km uphill)
Group sports Different physical activities (e.g. ball
games, dancing and gymnastics)
Focus on playing and having fun 1x/week à 45-90 min
Postural
training
Strength training: gymnastics,
dumbbells, stretch bands, etc.
Strength training to achieve or
maintain good posture
1x/week à 45 min
Hiking 10-12 km hikes in the mountains Endurance training with nature
experience
1x/week à 3 h
Non structured
physical activity
(~6 h/week)
’Fun- Walk’ Walking to the town centre (~1 km
downhill, 1 km uphill); Time for
individual activities
Endurance training, having fun 1x/week à 2 h (in total)
Excursions Various excursions and activities like
playing miniature golf, sightseeing,
table tennis tournaments, etc.
Having fun, group activities to
improve social skills
Dimension of physical activity
varies; within 4 weeks of
intervention, it accounts for 6 h/
week
Obesity patient
training courses
(16 sessions
within 4 weeks)
Psychotherapy ￿ Developing rules for healthy eating
behavior
￿ Rigid versus flexible dieting
Improving self-esteem and body
perception, prevention of relapse.
5 session within 4 weeks à 45 min
￿ Recognition of signs of both hunger
and satiety
￿ Learning to enjoy food as well as to
cope with difficult situations
￿ Developing motivation for
participating in regular physical activity
Individual sessions if the children suffer
from psychosomatic, psycho-vegetative
and/or psychological diseases
Treating individual psychological
problems
1-3 individual sessions à 45 min/
week
Nutritional
lessons
Teaching children to choose the
appropriate (amount of) food according
to their personal needs
Enabling the children to prepare
healthy food for themselves
5 sessions within 4 weeks à 45 min
Physical
education
Improving knowledge on energy
balance, effects and limitations of
physical activity, measures of self-
control and good posture
Increase knowledge of the effects
of physical activity to support
adherence to the regular physical
activity recommendations
4 sessions within 4 weeks à 45 min
Medical
education
Improving knowledge on medical
background of overweight and obesity
(normal/ideal weight, BMI,
comorbidities etc.)
Increase knowledge of the
medical consequences of
overweight and obesity and
promote a realistic goal setting
2 sessions within 4 weeks à 45 min
Social
competence
Training
sessions
￿ Training for conflict resolution,
communication, ability to offer and
receive criticism, body language, self-
assurance, empathy etc.
￿ Role playing
￿ Concentration training
￿ Development of emotional-
cognitive abilities
￿ Development of occupational
skills
￿ Reflecting on and improving
social behavior skills
1x/week à 45 min
Nutrition Cooking Cooking as a creative activity and a
positive group experience
Transfer of theoretical knowledge
into practice
1x/week, 2 h
Lessons for
grocery
shopping
￿ Learning how to read packaging
labels correctly (e.g. sample sizes,
nutritional information)
￿ Learning how to make educated
nutritional decisions about potentially
misleading products (e.g. ‘organic’)
Enabling the children to judge
different food products correctly
1x/week, 90 min
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Visits 3, 4 and 5
Prior to the first follow-up examination, which takes
place 6 months after the start of the program (Visit 3),
study investigators contact the general practitioners by
telephone to inform them about the study procedures
and to obtain agreement on carrying out the upcoming
follow-up examinations. The general practitioners are
asked to complete and return a standardized examina-
tion sheet including anthropometric measurements
(body weight, height and waist circumference), blood
pressure and Tanner stage as well as comorbidities and
the current use of medication.
In addition, study investigators contact the children
prior to each visit (6 months, 1 year and 2 years after
the start of the intervention) to remind them of the
upcoming examination and to enquire about possible
address changes. The children are requested to complete
the questionnaires, previously sent by post, and to
return them using the provided prepaid envelope as well
as to visit their general practitioner for the follow-up
examination. If both the questionnaires and the
Table 4 Overview of the data collection from visit 1 to visit 7
Setting Inpatient intervention Outpatient follow-ups (In/)outpatient follow-ups
VISIT VISIT 1 VISIT 2 VISIT 3 VISIT 4 VISIT 5 VISIT 6 VISIT 7
Time point Intervention start Intervention end 1/2 y 1 y 2 y 5 y 10 y
Physical examination
Anthropometry* + + + + + + +
Pubertal stage (Tanner) + + + + + +
Comorbidities/Medication + + + + + + +
Genetic and blood parameters
Collection of EDTA +
All blood parameters** + + (+) (+)
HDL, LDL, total cholesterol, triglycerides, glucose + + + +
Physical fitness and activity
Physical fitness (ergometry) + + (+) (+)
6-Minutes running test + + (+) (+)
Pedometer*** + (+) (+)
Questionnaires (filled in by children)
Quality of life (KINDL) + + + + + + +
Diet/Dietary intake + + + + + + +
Physical activity + + + + + + +
Questionnaire (filled in by parents)
Family background +
*body weight, body height, waist circumference, blood pressure.
**HDL, LDL, total cholesterol, triglycerides, glucose, proinsulin, insulin, uric acid, TSHbasal, adiponectin, leptin, RBP-4, resistin, high sensitive CRP, IL-6, TNFa.
***subgroup analysis.
Table 3 Components of the inpatient weight-loss program (Continued)
Parents Supportive
training
Parents receive background information
on obesity and advice about how to
best support their child. In addition,
they are requested to take their child to
subsequent outpatient psychological
treatment. They also receive special
handouts about healthy living,
including nutrition, physical activity,
media consumption etc.
Improving parental support of
the children after conclusion of
the inpatient program
Two conversations with the
physician (at the start and the end
of intervention. In special cases,
parents are contacted by
telephone)
School Theoretical
lessons
German, English and Mathematics Keeping the children current
with the appropriate educational
curriculum
Groups 3 and 4: 5x/week à 45 min
Groups 1 and 2: 6x/week à 45 min
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children will receive an allowance of 10 Euros.
Visits 6 and 7
For the 5 and 10 year follow-up examinations, the chil-
dren are invited to visit the study centre at the Depart-
ment of Prevention, Rehabilitation and Sports Medicine,
Technical University of Munich, where the same mea-
s u r e m e n t sa sa tb a s e l i n e( V i s i t1 )a r ep l a n n e dt ob e
obtained (except for DNA and family history). Children,
who are not able to visit the study centre, have blood
samples taken by their general practitioner in addition
to the basic examination as carried out for the previous
follow-up examinations. The blood parameters analysed
are fasting HDL, LDL, total cholesterol, triglycerides and
glucose. The allowance for each of this visit is 20 Euros.
At all visits, children whose documents have not been
returned to the study center are contacted by telephone,
repeatedly if necessary, in order to collect the missing
documents. If children wish to withdraw from the study
in spite of efforts to motivate them to continue partici-
pating, study investigators fill out an official drop out
sheet.
Statistical considerations
Associations between polymorphisms in adiposity-rele-
vant genes (FTO, MC4R, TMEM-18)a n dc h a n g e si n
BMI(-SDS) from the start to the end of the intervention,
will be assessed using analysis of covariance (ANCOVA)
models comparing mean changes in BMI(-SDS) between
the two groups of homozygous and the group of hetero-
zygous children adjusted for age, sex and baseline
weight. A two-sided level of significance of a = 0.05 will
be used. For pairwise group comparisons, two-sample t-
tests will be conducted using a Bonferroni-adjusted level
of significance of a* = 0.0167.
Middle and long-term associations between genes and
measures of interest such as weight change, physical fit-
ness and physical activity will analogously be analysed in
an explorative manner. Linear regression models includ-
ing all relevant genes plus baseline weight, age and sex
will be fit into estimate predictive models for the
expected short and long-term weight changes. Predictive
accuracy of the models and most relevant genes will be
assessed using re-sampling methods (e.g. bootstrap)
[42]. To estimate the influence of genes on relevant
measures over time, a mixed model will be fit to
account for multiple measures in the same participants.
Missing values will be replaced using multiple imputa-
tion methods based on observed values with varying
assumptions. Differences in the results obtained by dif-
ferent imputation strategies will be reported and
discussed.
With a sample size of 1,500 children the study is suffi-
ciently powered to detect significant differences in all
pairwise comparisons between allele groups on an
adjusted two-sided level of significance of a* = 0.0167, if
the true difference in means is at least half of the com-
mon standard deviation translating to an effect size of
0.5 (power > 90% for each pairwise comparison). The
sample size calculation is based on the assumption that
the distribution of alleles leading to the smallest sub-
groups will be 70%, 25% and 5%, hence the smallest
sample sizes for pairwise comparisons will be 375 versus
75 children. Sample size estimation was conducted for a
two-sample t-test with unequal group sizes using the
software nQuery (Version 7.0).
Discussion
This manuscript provides an outline of the rationale and
the design of the LOGIC-trial, which is the first study
that evaluates the short, middle and long-term effects of
an inpatient weight-loss program in association with
genetic factors in a large group of children and adoles-
cents (aimed sample size n = 1,500) and includes fol-
low-up measurements over 10 years. Hence, this study
will allow the investigation of important determinants of
successful weight-loss, particularly the role of a specific
genetic predisposition. To achieve this, a large amount
of data is being collected, on anthropometry, blood
parameters (adipokines and inflammatory markers), phy-
sical fitness, physical activity and quality of life.
To our knowledge, only 24 evaluated inpatient pro-
grammes have been published, of which merely 14 car-
ried out follow-up assessments. In all studies but one
the follow-up periods lasted no longer than three years.
No study has ever carried out follow-up measurements
after more than five years following an inpatient weight-
loss program [18,22-24]. Therefore, our study is unique
particularly regarding the 5 and 10 year follow-up mea-
surements and allows investigating the tracking of the
effects of an inpatient lifestyle intervention from child-
hood to adolescence and adulthood. In addition, the
l a r g es a m p l es i z eo f1 , 5 0 0c h i l d r e na l l o w sat h o r o u g h
investigation of the genetic questions of interest. The
question of genetic predisposition is particularly inter-
esting regarding obesity and weight change, as obesity is
considered as a polygenic syndrome with various SNPs
involved. To date, however, the impact of the SNP’so n
the individual responses to obesity treatment in children
is still unclear. The studies that have shown an influence
of genetic factors on changes in body weight induced by
a lifestyle intervention in children [25-30] had relatively
small sample sizes (n = 236 to n = 519) and have shown
inconsistent results. A clear advantage of the LOGIC-
trial protocol is the inclusion of adipokines and inflam-
matory markers, as well as objective measures of physi-
cal fitness, which will allow investigations of the
associations between changes in body weight,
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are of particular relevance in light of potentially impor-
tant links between these parameters as indicated by a
recent review [7]. Some studies have shown relevant
associations between adipokines and weight-loss induced
by lifestyle interventions [43-46], whereas particularly
the results concerning the associations between adipo-
kines and physical fitness are equivocal. This can be
explained by the small sample sizes and different outpa-
tient study settings [47-51]. A further strength of the
LOGIC-trial is that all anthropometrical parameters are
taken by either a nurse or a general practitioner. This
avoids the underestimation of body weight that is often
observed in self-reports [52]. The inpatient setting is
standardised in that participants are living in a con-
trolled environment with similar dietary and exercise
conditions and intervention. Such a controlled setting is
particularly important for the investigation of the influ-
ence of genetic factors, which can be strongly con-
founded by environmental conditions [15].
Our study has a few limitations, which cannot be
completely avoided in this real-life setting. This is an
observational study and not a randomized controlled
trial. In a randomized design with a 10 year follow-up
time it would be ethically questionable to randomize
children into an inpatient weight-loss programme and a
control group, as the children from the control group
would not be allowed to take part in the lifestyle inter-
vention during that time. In addition, the primary inten-
tion of this study is to investigate the inter-individual
variability of the effects of the intervention depending
on the children’s genotypes, which does not necessarily
require a control group. For cross-sectional analyses, we
use an age-matched sample of normal weight children
of a school-based intervention study [53] as well a
cohort of young athletes, who are recruited at the
Department of Prevention, Rehabilitation and Sports
Medicine, Technical University of Munich.
As we recruit a selected cohort of children who take
part in a specialized obesity program it has to be consid-
ered that data from clinical samples may not be repre-
sentative for general populations. Furthermore, although
we do have objective physical activity measurements
during the intervention, long-term physical activity is
assessed by questionnaires. It has been planned this way
as we require a standardised physical activity assessment
method that can be carried out by all participants for
every follow-up measurement during this 10 year time
period. Considering the inclusion of 1,500 children and
in total seven measurement time points, objective physi-
cal activity measurements would have been almost
impossible. Similar to the physical activity, nutritional
behavior and intake is assessed by questionnaire. Again,
more objective measurements such as dietary records
would have been optimal but logistically difficult to inte-
grate. In order to maintain high the compliance of the
participants we tried to develop and carry out follow-up
examinations that are valid, practical and not too time
c o n s u m i n g .T h e r e f o r ew ea r en o tu s i n gad e t a i l e df o o d
frequency questionnaire.
In summary, this is the first lifestyle intervention study
with a detailed assessment of short, middle and long-
term weight changes, physical fitness, cardiometabolic
risk factors including both inflammatory markers and
adipokines in a large cohort of overweight and obese
children. Apart from elucidating the short-term effects
of this supervised weight-loss program, this study will
provide the outstanding opportunity to investigate the
tracking of the immediate effects of a lifestyle interven-
tion on body weight and the cardiometabolic risk profile
from childhood into adolescence and adulthood under
consideration of the influence of genetic predisposition.
This will contribute to a better understanding of inter-
individual differences in the regulation of body weight
and thus may lead to an optimization of personalized
treatment strategies for childhood obesity.
Endnotes
aBased on clinic internal considerations this has been
changed from 1,200-1,800 to 1,250-1,800 kcal per day in
the year 2010.
bBased on clinic internal considerations this has been
changed from 11 to 10 h per day in the year 2011.
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